Ergoteles LLC - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 29 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2023$23,282
-54.5%
15,521
-54.8%
0.00%
-50.0%
Q4 2022$51,167
-63.2%
34,340
-61.8%
0.00%
-60.0%
Q3 2022$139,000
-34.4%
89,967
-3.9%
0.01%
-16.7%
Q2 2022$212,00093,5980.01%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Alpha Wave Global, LP 213,658$3,104,0000.19%
Serengeti Asset Management LP 20,000$291,0000.13%
FORMULA GROWTH LTD 56,276$818,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 375,000$5,449,0000.12%
TUDOR INVESTMENT CORP ET AL 113,353$1,647,0000.03%
Duquesne Family Office 100,000$1,453,0000.03%
PURA VIDA INVESTMENTS, LLC 67,357$941,0000.03%
MOORE CAPITAL MANAGEMENT, LP 127,500$1,853,0000.02%
Zimmer Partners, LP 46,000$668,0000.01%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 26,000$376,0000.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders